Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Journal of Molecular Medicine

• Publication date

  2010-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJMM_00000445PMID 20514433PMCID PMC3044435
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aldose reductase inhibition suppresses airway inflammation.

  2011cited by this paper
• Early Neural and Vascular Dysfunctions in Diabetic Rats Are Largely Sequelae of Increased Sorbitol Oxidation

  2010cited by this paper
• Polyol pathway impairs the function of SERCA and RyR in ischemic-reperfused rat hearts by increasing oxidative modifications of these proteins.

  2010cited by this paper
• The role of the polyol pathway in acute kidney injury caused by hindlimb ischaemia in mice

  2010cited by this paper
• Identification of novel pharmacological targets to minimize excitotoxic retinal damage.

  2009cited by this paper
• Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.

  2009cited by this paper
• The Aldose Reductase Inhibitor Fidarestat Suppresses Ischemia-Reperfusion-Induced Inflammatory Response in Rat Retina

  2009cited by this paper
• Cyclooxygenase-2 plays a critical role in retinal ganglion cell death after transient ischemia: real-time monitoring of RGC survival using Thy-1-EGFP transgenic mice.

  2009cited by this paper
• Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.

  2009cited by this paper
• Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis.

  2009cited by this paper
• Aldose reductase deficiency in mice prevents azoxymethane-induced colonic preneoplastic aberrant crypt foci formation.

  2009cited by this paper
• Aldose Reductase Protects Against Early Atherosclerotic Lesion Formation in Apolipoprotein E–Null Mice

  2009cited by this paper
• Aldose Reductase Inhibition Suppresses the Expression of Th2 Cytokines and Airway Inflammation in Ovalbumin-Induced Asthma in Mice1

  2009cited by this paper
• Pycnogenol® Improves Microcirculation, Retinal Edema, and Visual Acuity in Early Diabetic Retinopathy

  2009cited by this paper
• Inflammatory Markers in Nondiabetic and Diabetic Rat Retinas Exposed to Ischemia Followed by Reperfusion

  2008cited by this paper
• Role of the polyol pathway in high glucose-induced apoptosis of retinal pericytes and proliferation of endothelial cells.

  2008cited by this paper
• Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro.

  2008cited by this paper
• Deleterious role of TNF-alpha in retinal ischemia-reperfusion injury.

  2008cited by this paper
• Increased expression of IRE1α and stress-related signal transduction proteins in ischemia-reperfusion injured retina

  2008cited by this paper
• Nicotinamide attenuates retinal ischemia and light insults to neurones.

  2008cited by this paper
• Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts

  2008cited by this paper
• Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.

  2008cited by this paper
• Pathogenesis of Spinally Mediated Hyperalgesia in Diabetes

  2007cited by this paper
• Nitric oxide and peroxynitrite in health and disease.

  2007cited by this paper
• Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes.

  2007cited by this paper
• Pathogenesis of Spinally Mediated Hyperalgesia in

  2007cited by this paper
• Gene deletion and pharmacological inhibition of aldose reductase protect against retinal ischemic injury.

  2007cited by this paper
• Aldose reductase inhibition prevents endotoxin-induced uveitis in rats.

  2007cited by this paper
• Aldose Reductase–Deficient Mice Are Protected From Delayed Motor Nerve Conduction Velocity, Increased c-Jun NH2-Terminal Kinase Activation, Depletion of Reduced Glutathione, Increased Superoxide Accumulation, and DNA Damage

  2006cited by this paper
• Aldose reductase inhibitors improve myocardial reperfusion injury in mice by a dual mechanism.

  2006cited by this paper
• A Selective Aldose Reductase Inhibitor of a New Structural Class Prevents or Reverses Early Retinal Abnormalities in Experimental Diabetic Retinopathy

  2006cited by this paper
• Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.

  2006cited by this paper
• Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.

  2005cited by this paper
• A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes.

  2005cited by this paper
• Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells.

  2005cited by this paper
• Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.

  2005cited by this paper
• Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice.

  2005cited by this paper
• Increased Sorbitol Pathway Activity Generates Oxidative Stress in Tissue Sites for Diabetic Complications

  2005cited by this paper
• Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration

  2005cited by this paper
• Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase.

  2004cited by this paper
• From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines.

  2004cited by this paper
• Effects of polyol pathway hyperactivity on protein kinase C activity, nociceptive peptide expression, and neuronal structure in dorsal root ganglia in diabetic mice.

  2004cited by this paper
• Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.

  2004cited by this paper
• Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase.

  2004cited by this paper
• Central role for aldose reductase pathway in myocardial ischemic injury

  2004cited by this paper
• Neuronal susceptibility to damage: comparison of the retinas of young, old and old/caloric restricted rats before and after transient ischemia.

  2004cited by this paper
• High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation.

  2003cited by this paper
• Diabetes can alter the signal transduction pathways in the lens of rats.

  2003cited by this paper
• Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats.

  2003cited by this paper
• Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats.

  2003cited by this paper
• Plasma 3-deoxyglucosone elevation in chronic renal failure is associated with increased aldose reductase in erythrocytes.

  2002cited by this paper
• An aldose reductase inhibitor reverses early diabetes‐induced changes in peripheral nerve function, metabolism, and antioxidative defense

  2002cited by this paper
• Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury

  2002cited by this paper
• Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor.

  2001cited by this paper
• Diabetes-Induced Changes in Retinal NAD-Redox Status

  2001cited by this paper
• Impaired inhibitory G-protein function contributes to increased calcium currents in rats with diabetic neuropathy.

  2001cited by this paper
• Inhibition of Sorbitol Dehydrogenase Exacerbates Autonomic Neuropathy in Rats with Streptozotocin‐Induced Diabetes

  2001cited by this paper
• Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats.

  2000cited by this paper
• Retinal and choroidal neovascularization

  2000cited by this paper
• Effects of aldose reductase inhibition on responses of the corpus cavernosum and mesenteric vascular bed of diabetic rats.

  2000cited by this paper
• Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study

  2000cited by this paper
• Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes.

  2000cited by this paper
• Epalrestat , an Aldose Reductase Inhibitor , Reduces the Levels of N ε-( Carboxymethyl ) lysine Protein Adducts and Their Precursors in Erythrocytes From Diabetic Patients

  2000cited by this paper
• A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.

  1999cited by this paper
• Quantitative analysis of diabetic macular edema after scatter laser photocoagulation with the scanning retinal thickness analyzer.

  1999cited by this paper
• Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.

  1999cited by this paper
• Complications

  1999cited by this paper
• Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study

  1999cited by this paper
• Interaction between osmotic and oxidative stress in diabetic precataractous lens: studies with a sorbitol dehydrogenase inhibitor.

  1999cited by this paper
• Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.

  1998cited by this paper
• Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.

  1998cited by this paper
• Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

  1998cited by this paper
• The b-wave of the electroretinogram as an index of retinal ischemia.

  1998cited by this paper
• Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats

  1997cited by this paper
• Effect of an aldose reductase inhibitor on abnormalities of electroretinogram and vascular factors in diabetic rats.

  1997cited by this paper
• Dose-Dependent Reduction of Retinal Vessel Changes Associated with Diabetic Retinopathy in Galactose-Fed Dogs by the Aldose Reductase Inhibitor M79175

  1997cited by this paper
• Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.

  1996cited by this paper
• Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens.

  1995cited by this paper
• Metabolism of fructose-3-phosphate in the diabetic rat lens.

  1995cited by this paper
• Blood-retinal barrier breakdown following experimental retinal ischemia and reperfusion.

  1995cited by this paper
• Inhibition of Sorbitol Dehydrogenase: Effects on Vascular and Neural Dysfunction in Streptozocin-Induced Diabetic Rats

  1995cited by this paper
• Diabetic retinopathy

  1995cited by this paper
• Suppression of Pentosidine Formation in Galactosemic Rat Lens by an Inhibitor of Aldose Reductase

  1994cited by this paper
• Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor Statil.

  1993cited by this paper
• [The mechanism of the formation of seminal fructose and fetal fructose].

  1960cited by this paper
• Le mécanisme de la formation du fructose séminal et du fructose foetal

  1960cited by this paper

• Molecular stress and neurovascular injury in the diabetic retina.

  2026cites this paper
• Comparative Evaluation of Aldose Reductase Inhibition in Polycystic Ovarian Syndrome–Induced Rats

  2022cites this paper
• BIOCHEMICAL BASIS AND EMERGING MOLECULAR TARGETS TO TREAT DIABETIC RETINOPATHY

  2016cites this paper
• Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy

  2016cites this paper
• Molecular Mechanisms of Diabetic Retinopathy: Potential Therapeutic Targets

  2015cites this paper
• Molecular Mechanisms of Diabetic Retinopathy, General Preventive Strategies, and Novel Therapeutic Targets

  2014cites this paper
• Title Hypoxia-induced oxidative stress in ischemic retinopathy

  2013cites this paper
• Ischemic postconditioning during reperfusion attenuates oxidative stress and intestinal mucosal apoptosis induced by intestinal ischemia/reperfusion via aldose reductase.

  2013cites this paper
• Aldose Reductase Inhibitors as Potential Therapeutic Drugs of Diabetic Complications

  2013cites this paper
• Recent advances in cellular and molecular aspects of mammalian retinal ischemia

  2012cites this paper
• Hypoxia-Induced Oxidative Stress in Ischemic Retinopathy

  2012cites this paper
• Mechanism of diabetic neuropathy: Where are we now and where to go?

  2010cites this paper